Published in Bull World Health Organ on January 01, 1971
Clinical management of field worker organophosphate poisoning. West J Med (1985) 2.27
Pesticide exposures, cholinesterase depression, and symptoms among North Carolina migrant farmworkers. Am J Public Health (1994) 1.90
Self reported symptoms and inhibition of acetylcholinesterase activity among Kenyan agricultural workers. Occup Environ Med (2000) 1.42
Pesticide Use and Self-Reported Symptoms of Acute Pesticide Poisoning among Aquatic Farmers in Phnom Penh, Cambodia. J Toxicol (2010) 1.11
Assessment of exposure to organophosphate insecticides during spraying in Haiti: monitoring of urinary metabolites and blood cholinesterase levels. Bull World Health Organ (1985) 1.03
Clinical features of organophosphate poisoning: A review of different classification systems and approaches. Indian J Crit Care Med (2014) 0.96
Management of acute organophosphorus pesticide poisoning. BMJ (2007) 0.94
Safety measures associated with the use of organophosphate insecticides in the Haitian malaria control programme. Bull World Health Organ (1985) 0.87
Zebrafish Models for Human Acute Organophosphorus Poisoning. Sci Rep (2015) 0.87
Laboratory and field microassay of cholinesterases in whole blood, plasma, and erythrocytes. Bull World Health Organ (1987) 0.75
A case of acute pancreatitis with occupational exposure to organophosphorus compound. Toxicol Int (2012) 0.75
Study of Effect of Magnesium Sulphate in Management of Acute Organophosphorous Pesticide Poisoning. Anesth Essays Res (2017) 0.75
Poisoning due to organophosphate insecticides. Acute and chronic manifestations. Am J Med (1971) 5.20
A powerful reactivator of alkylphosphate-inhibited acetylcholinesterase. Biochim Biophys Acta (1955) 2.91
Drug-induced changes in brain acetylcholine. Br J Pharmacol Chemother (1962) 2.76
The effect of anti-cholinesterase agents on the rat's blood pressure. Br J Pharmacol Chemother (1955) 2.15
Safety of malathion dusting powder for louse control. Bull World Health Organ (1960) 1.77
PAM (pyridine-2-aldoxime methiodide) therapy for alkyl-phosphate poisoning. J Am Med Assoc (1958) 1.66
Organic phosphorus poisoning and its therapy. With special reference to modes of action and compounds that reactivate inhibited cholinesterase. Arch Environ Health (1962) 1.52
COMPLETE PSEUDOCHOLINESTERASE DEFICIENCY: GENETIC AND IMMUNOLOGIC CHARACTERIZATION. J Clin Invest (1965) 1.43
[Effects of physostigmine, tetraethylpyrophosphate, and neostigmine on the blood pressure and pressor reflexes of the carotid sinus in rats]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1956) 1.30
Psychiatric sequelae of chronic exposure to organophosphorus insecticides. Lancet (1961) 1.26
Recent studies of organic phosphate poisoning. Fed Proc (1959) 1.18
Controlled human exposures to malathion aerosols. AMA Arch Ind Health (1959) 1.17
Plasma and red blood cell cholinesterase activity as indications of the threshold of incipient toxicity of ethyl-p-nitrophenyl thionobenzenephosphonate (EPN) and malathion in human beings. Toxicol Appl Pharmacol (1962) 1.12
TREMORINE AND ATROPINE EFFECTS ON BRAIN ACETYLCHOLINE. Life Sci (1963) 1.09
The effects of anticholinesterases upon peripheral vascular resistance in the dog. J Physiol (1956) 1.04
Pesticide poisoning in south Florida. An analysis of mortality and morbidity and a comparison of sources of incidence data. Arch Environ Health (1968) 1.04
Toxicity of diacetyl monoxime and of pyridine-2-aldoxime methiodide in man. Bull Johns Hopkins Hosp (1958) 0.98
Cholinesterase activity of motor end plate in human skeletal muscle. J Clin Invest (1970) 0.98
Malathion poisoning. A fatal case with cardiac manifestations. Arch Environ Health (1970) 0.97
Erythrocyte acetylcholinesterase deficiency in paroxysmal nocturnal hemoglobinuria (PNH). A comparison of the complement-sensitive and insensitive populations. Blood (1969) 0.95
Human toxicity of various oximes. 2-Pyridine aldoxime methyl chloride, its methane sulfonate salt, and 1,1'-trimethylenebis-(4-formylpyridinium chloride). Arch Environ Health (1967) 0.93
Growth and respiration of monolayer cell cultures of chick embryo heart and skeletal muscle: action of malathion and malaoxon. Proc Soc Exp Biol Med (1969) 0.87
Feasibility of prophylaxis by oral pralidoxime. Cholinesterase inactivation by organophosphorus pesticides. Arch Environ Health (1968) 0.86
Changes following anticholinesterase exposures. Blood coagulation studies. Arch Environ Health (1961) 0.85
OXIMES ANTAGONISTIC TO INHIBITORS OF CHOLINESTERASE. II. J Pharm Sci (1964) 0.84
Efficacy and limitations of oxime-atropine treatment of organophosphorus anticholinesterase poisoning. J Pharmacol Exp Ther (1961) 0.84
[PHARMACOLOGIC-TOXICOLOGIC STUDIES WITH THE DICHLORIDE OF BIS-(4-HYDROXYIMINOMETHYL-1-PYRIDINIUM-METHYL)-ETHER, A NEW ESTERASE REACTIVATOR]. Arzneimittelforschung (1964) 0.83
The occurrence and significance of pesticide residues in wild animals. Ann N Y Acad Sci (1969) 0.82
Effect of sarin on the cardio-inhibitory, vasomotor and respiratory centers of the isolated head in dogs. Arch Int Pharmacodyn Ther (1959) 0.81
[Study of the pharmacological action of tetraethylpyrophosphate (TEPP)]. Arch Int Pharmacodyn Ther (1954) 0.81
THE POSSIBLE BIOLOGICAL FUNCTION OF PSEUDOCHOLINESTERASE. Nature (1963) 0.81
[Treatment of parathion (E 605) poisoning with the cholinesterase-reactivating substance obidoxime (Toxogonin)]. Arch Toxikol (1969) 0.81
[A NEW ESTERASE REACTIVATOR FOR THE TREATMENT OF ALKYLPHOSPHATE POISONINGS]. Dtsch Med Wochenschr (1963) 0.79
Insecticides, rodenticides, herbicides; household hazards. Postgrad Med (1958) 0.79
EFFECT OF PHOSPHOLINE IODIDE ON BLOOD CHOLINESTERASE LEVELS OF NORMAL AND GLAUCOMA SUBJECTS. Am J Ophthalmol (1965) 0.79
TOXOGONIN IN SARIN, SOMAN AND TABUN POISONING. Biochem Pharmacol (1965) 0.79
Comparative anticholinesterase action of organophosphorus insecticides in vertebrates. Toxicol Appl Pharmacol (1968) 0.78
[Suicidal poisoning by subcutaneous injection of a mixture of parathion and demeton-o-methyl sulfoxide (E 605 MR)]. Arch Toxikol (1970) 0.77
MALATHION POISONING SUCCESSFULLY TREATED WITH LARGE DOSES OF ATROPINE. Can Med Assoc J (1964) 0.77
POISONING DUE TO PARATHION AND OTHER ORGANOPHOSPHORUS INSECTICIDES IN DENMARK. Dan Med Bull (1964) 0.77
[THE ANTIDOTE EFFECT OF BIS-(4-HYDROXYIMINOMETHYL-1-PYRIDINIUMMETHYL)-ETHER DICHLORIDE IN ALKYLPHOSPHATE-POISONED RATS]. Arzneimittelforschung (1964) 0.77
[COMPARATIVE STUDIES ON THE POSSIBILITY OF PENETRATION OF SOME ESTERASE-ACTIVATING OXIMES INTO THE CENTRAL NERVOUS SYSTEM]. Arzneimittelforschung (1965) 0.77
[On a successfully treated acute oral Fenthion poisoning and its traces in stomach contents and urine]. Arch Toxikol (1966) 0.77
[Limits of therapy with oximes in poisoning with insecticidal alkylphosphates]. Arzneimittelforschung (1967) 0.77
Aerial application accidents 1963 to 1966. An analysis of the principal factors. Arch Environ Health (1968) 0.77
Nerve gas. Dugway accident linked to Utah sheep kill. Science (1968) 0.77
[Auricular fibrillation in alkylphosphate poisoning]. Wien Klin Wochenschr (1968) 0.77
Parathion poisoning in Punjab (a clinical and electrocardiographic study of 20 cases). J Assoc Physicians India (1969) 0.77
Chlorinated hydrocarbon insecticide content of the neonate. Ann N Y Acad Sci (1969) 0.77
Acetylcholine content in the brain of rats treated with paraoxon and pyridinium-2-aldoxime methylchloride. J Pharm Pharmacol (1969) 0.77
Blood levels of oxime and symptoms in humans after single and multiple oral doses of 2-pyridine aldoxime methochloride. J Pharm Sci (1969) 0.77
[A severe percutaneous poisoning with parathion (E 605)]. Arch Toxikol (1969) 0.77
[Occupational injuries due to E 605]. Med Klin (1951) 0.77
[New experiences in the toxicologically controlled therapy of an unusually serious poisoning with nitrostigmine (E605 forte)]. Dtsch Med Wochenschr (1970) 0.77
Acetylcholine content in the brain of rats treated with paraoxon and obidoxime. Br J Pharmacol (1970) 0.77
[Studies on liver toxicity of obidoxim (Toxogonin) in humans]. Dtsch Med Wochenschr (1970) 0.76
[RESORPTION AND EXCRETION OF TOXOGONIN FOLLOWING INTRAMUSCULAR INJECTION IN MAN]. Dtsch Med Wochenschr (1965) 0.76
Pesticide intoxications in Arizona. Ariz Med (1969) 0.76
Oral administration of pralidoxime chloride in echothiophate iodide therapy. Arch Ophthalmol (1969) 0.76
[Hepatotoxicity of nitrostigmine (E 605 forte) and obidoxime (Toxogonin) in dogs]. Arch Toxikol (1970) 0.76
On a successfully treated acute oral paraoxone (E 600) poisoning. Arch Toxikol (1969) 0.76
Poisoning with monocrotophos, an organophosphorus pesticide. Med J Aust (1969) 0.76
[SUCCESSFUL TREATMENT OF E-605 POISONING WITH A NEW CHOLINESTERASE REACTIVATOR]. Arztl Forsch (1963) 0.76
[Antidotal therapy in alkylphosphate poisoning]. Arch Toxikol (1968) 0.76
[Penetration of 14C-obidoxime through the so-called blood-brain barrier of mice and rats]. Arch Toxikol (1969) 0.76
[Cholestatic hepatosis following toxogonin treatment in a clinical case of alkylphosphate poisoning]. Med Klin (1968) 0.76
Malathion inhibition of esterases as a determinant of malathion toxicity. J Pharmacol Exp Ther (1967) 0.76
Treatment of malathion poisoning. Experience of two cases in Sarawak. Anaesthesia (1970) 0.76
[On a case of occupational poisoning by Mevinphos]. Arch Toxikol (1966) 0.76
Review of 210 deaths by poisoning in British Guiana (1959-1964). West Indian Med J (1966) 0.76
[Effect of E 605 poisoning and specific antidote therapy on the liver function of rabbits]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1969) 0.76
Poisoning due to organophosphate insecticides. Acute and chronic manifestations. Am J Med (1971) 5.20
Prolonged weakness after long-term infusion of vecuronium bromide. Ann Intern Med (1992) 3.36
Neonatal myasthenia gravis: report of two cases and review of the literature. Pediatrics (1970) 2.29
Staining for nerve fiber and cholinesterase activity in fresh frozen sections. Am J Clin Pathol (1967) 2.01
Cloning and expression of a cDNA for mouse prostaglandin E receptor EP3 subtype. J Biol Chem (1992) 1.75
Cloning and expression of cDNA for a mouse EP1 subtype of prostaglandin E receptor. J Biol Chem (1993) 1.72
The course of myasthenia gravis and therapies affecting outcome. Ann N Y Acad Sci (1987) 1.62
Cloning and expression of a cDNA for mouse prostaglandin E receptor EP2 subtype. J Biol Chem (1993) 1.61
High-dose intravenous immunoglobulin in the management of myasthenia gravis. Arch Intern Med (1986) 1.56
Processing of nux vomica. II. Changes in alkaloid composition of the seeds of Strychnos nux-vomica on traditional drug-processing. Chem Pharm Bull (Tokyo) (1990) 1.52
Targeting endogenous platelet-derived growth factor B-chain by adenovirus-mediated gene transfer potently inhibits in vivo smooth muscle proliferation after arterial injury. Gene Ther (1999) 1.51
Volcanic production of polyphosphates and its relevance to prebiotic evolution. Nature (1991) 1.47
Potent inhibitors of tyrosinase activity and melanin biosynthesis from Rheum officinale. Planta Med (1995) 1.39
Familial myasthenia gravis. Report of 27 patients in 12 families and review of 164 patients in 73 families. Arch Neurol (1971) 1.38
Two isoforms of the EP3 receptor with different carboxyl-terminal domains. Identical ligand binding properties and different coupling properties with Gi proteins. J Biol Chem (1993) 1.37
Anastomotic aneurysms after surgical treatment of Takayasu's arteritis: a 40-year experience. J Vasc Surg (1998) 1.35
Third isoform of the prostaglandin-E-receptor EP3 subtype with different C-terminal tail coupling to both stimulation and inhibition of adenylate cyclase. Eur J Biochem (1993) 1.33
In situ hybridization studies of prostacyclin receptor mRNA expression in various mouse organs. Br J Pharmacol (1995) 1.33
Four di-O-caffeoyl quinic acid derivatives from propolis. Potent hepatoprotective activity in experimental liver injury models. Biol Pharm Bull (1996) 1.28
Myasthenia gravis in patients with thymoma, with particular reference to onset after thymectomy. Medicine (Baltimore) (1978) 1.28
The natural course of myasthenia gravis and effect of therapeutic measures. Ann N Y Acad Sci (1981) 1.27
Studies on dental caries prevention by traditional medicines. VIII. Inhibitory effect of various tannins on glucan synthesis by glucosyltransferase from Streptococcus mutans. Chem Pharm Bull (Tokyo) (1986) 1.26
Idiopathic giant cell polymyositis. Report of a case and review of the syndrome. Arch Neurol (1974) 1.25
Anti-inflammatory effects of emodin from ventilago leiocarpa. Am J Chin Med (1996) 1.23
Celecoxib upregulates endoplasmic reticulum chaperones that inhibit celecoxib-induced apoptosis in human gastric cells. Oncogene (2006) 1.23
Role of nitric oxide towards vasodilator effects of substance P and ATP in human forearm vessels. Clin Sci (Lond) (1997) 1.22
Effect of tea polyphenols on glucan synthesis by glucosyltransferase from Streptococcus mutans. Chem Pharm Bull (Tokyo) (1990) 1.21
Clostridium botulinum C3 ADP-ribosyltransferase gene. Cloning, sequencing, and expression of a functional protein in Escherichia coli. J Biol Chem (1991) 1.20
Distribution of the messenger RNA for the prostaglandin E receptor subtype EP3 in the mouse nervous system. Neuroscience (1994) 1.19
Repetitive cocaine administration decreases neurogenesis in adult rat hippocampus. Ann N Y Acad Sci (2004) 1.19
Cholinesterase activity of the motor endplate in isolated muscle membrane. J Neurochem (1968) 1.19
Cloning and expression of a cDNA for mouse prostaglandin F receptor. J Biol Chem (1994) 1.15
High-dose intravenous methylprednisolone in myasthenia gravis. Arch Neurol (1985) 1.14
Analysis of a thread used in the Kshara Sutra treatment in the Ayurvedic medicinal system. J Ethnopharmacol (1990) 1.12
Antioxidative effects of phenylethanoids from Cistanche deserticola. Biol Pharm Bull (1996) 1.11
Metabolism of glycyrrhizin by human intestinal flora. Planta Med (1983) 1.11
Inhibitory effects of Egyptian folk medicines on human immunodeficiency virus (HIV) reverse transcriptase. Chem Pharm Bull (Tokyo) (1995) 1.11
Chronic proximal spinal muscular atrophy. J Neurol Sci (1970) 1.09
Corticotropin in generalized myasthenia gravis. Effect of short, intensive courses. JAMA (1966) 1.08
Diffuse myopathy related to meperidine addiction in a mother and daughter. Arch Neurol (1968) 1.07
Chondrodystrophic myotonia: report of two cases. Myotonia, dwarfism, diffuse bone disease, and unusual ocular and facial abnormalities. Arch Neurol (1970) 1.07
Thromboxane A2 receptor is highly expressed in mouse immature thymocytes and mediates DNA fragmentation and apoptosis. J Exp Med (1993) 1.07
Distinct cellular localization of mRNAs for three subtypes of prostaglandin E receptor in kidney. Am J Physiol (1994) 1.04
Metabolism of glycyrrhizin by human intestinal flora. II. Isolation and characterization of human intestinal bacteria capable of metabolizing glycyrrhizin and related compounds. Chem Pharm Bull (Tokyo) (1985) 1.04
Identification of prostaglandin E receptor 'EP2' cloned from mastocytoma cells EP4 subtype. FEBS Lett (1995) 1.04
Mechanism of antihepatotoxic activity of glycyrrhizin. I: Effect on free radical generation and lipid peroxidation. Planta Med (1984) 1.04
Anti-herpes simplex virus activity of moronic acid purified from Rhus javanica in vitro and in vivo. J Pharmacol Exp Ther (1999) 1.03
Hepatoprotective activity of phenylethanoids from Cistanche deserticola. Planta Med (1998) 1.02
Conduction velocity in the ulnar nerve in hemiplegic patients. J Neurol Sci (1971) 1.01
Preventive effect of lithospermate B from Salvia miltiorhiza on experimental hepatitis induced by carbon tetrachloride or D-galactosamine/lipopolysaccharide. Planta Med (1997) 1.00
Corticosteroids in management of severe, generalized myasthenia gravis. Effectiveness and comparison with corticotropin therapy. Neurology (1972) 1.00
Glial fibrillary acidic protein-expressing neural progenitors give rise to immature neurons via early intermediate progenitors expressing both glial fibrillary acidic protein and neuronal markers in the adult hippocampus. Neuroscience (2009) 0.99
Antiviral traditional medicines against herpes simplex virus (HSV-1), poliovirus, and measles virus in vitro and their therapeutic efficacies for HSV-1 infection in mice. Antiviral Res (1993) 0.99
Inhibition of nitric oxide by phenylethanoids in activated macrophages. Eur J Pharmacol (2000) 0.98
Cholinesterase activity of motor end plate in human skeletal muscle. J Clin Invest (1970) 0.98
Malathion poisoning. A fatal case with cardiac manifestations. Arch Environ Health (1970) 0.97
Effect of Cleistanthus collinus leaf extract on neuromuscular function of the isolated mouse phrenic nerve-diaphragm. Toxicon (1989) 0.97
Processing of nux vomica. VII. Antinociceptive effects of crude alkaloids from the processed and unprocessed seeds of Strychnos nux-vomica in mice. Biol Pharm Bull (1996) 0.97
Effect of serum and serum globulin of patients with myasthenia gravis on neuromuscular transmission. Neurology (1969) 0.96
Corticotropin therapy in myasthenia gravis: effects, indications, and limitations. Neurology (1971) 0.94
Bellidifolin: a potent hypoglycemic agent in streptozotocin (STZ)-induced diabetic rats from Swertia japonica. Planta Med (1994) 0.94
Molecular cloning of human prostacyclin receptor cDNA and its gene expression in the cardiovascular system. Circulation (1994) 0.94
Failure of neuromuscular transmission and contractility during muscle fatigue. Muscle Nerve (1985) 0.94
Autoantibodies and myasthenia gravis, with special reference to muscle ribonucleoprotein. Ann N Y Acad Sci (1966) 0.93
A rho gene product in human blood platelets. I. Identification of the platelet substrate for botulinum C3 ADP-ribosyltransferase as rhoA protein. J Biol Chem (1992) 0.93
Prophylactic treatment of cytomegalovirus infection with traditional herbs. Antiviral Res (1996) 0.93
Cloning and expression of a cDNA for the human prostacyclin receptor. FEBS Lett (1994) 0.93
Three phenylethanoid glycosides and an iridoid glycoside from Picrorhiza scrophulariiflora. Phytochemistry (1998) 0.92
Acteoside inhibits apoptosis in D-galactosamine and lipopolysaccharide-induced liver injury. Life Sci (1999) 0.91
Inhibitory effect of tannins on reverse transcriptase from RNA tumor virus. J Nat Prod (1985) 0.91
Active-oxygen scavenging activity of traditional nourishing-tonic herbal medicines and active constituents of Rhodiola sacra. J Ethnopharmacol (1999) 0.91
Antibacterial activity of trichorabdal A from Rabdosia trichocarpa against Helicobacter pylori. Zentralbl Bakteriol (1997) 0.90
Screening of Taiwanese crude drugs for antibacterial activity against Streptococcus mutans. J Ethnopharmacol (1989) 0.90
[Fundamental studies on the evaluation of the crude drugs. 3. Chemical and biochemical evaluation of ginseng and related crude drugs (author's transl)]. Yakugaku Zasshi (1974) 0.90
Alterations in reactivity to acetylcholine in myasthenia gravis and carcinomatous myopathy. Ann N Y Acad Sci (1966) 0.90
Evidence for an oscillatory signature in atmospheric neutrino oscillations. Phys Rev Lett (2004) 0.90
Association of myasthenia gravis with pemphigus vulgaris, Candida albicans infection, polymyositis and myocarditis. J Neurol Sci (1973) 0.90
Efficacy of traditional herbal medicines in combination with acyclovir against herpes simplex virus type 1 infection in vitro and in vivo. Antiviral Res (1995) 0.89
Purification and characterization of eugeniin as an anti-herpesvirus compound from Geum japonicum and Syzygium aromaticum. J Pharmacol Exp Ther (1998) 0.89
The use of ACTH and corticosteroids in myasthenia gravis. Ann N Y Acad Sci (1971) 0.89
Metabolism of sennosides by human intestinal bacteria. Pharmacology (1988) 0.88
Effects of aqueous extracts of Apocynum venetum leaves on spontaneously hypertensive, renal hypertensive and NaCl-fed-hypertensive rats. J Ethnopharmacol (2000) 0.88
Metabolism of sennosides by human intestinal bacteria. Planta Med (1980) 0.88
Skeletal muscle fatigue and physical endurance of young and old mice. Muscle Nerve (1998) 0.88
Studies on cardio-active crude drugs; I. Effect of coumarins on cultured myocardial cells. Planta Med (1988) 0.88
Signal transductions of three isoforms of mouse prostaglandin E receptor EP3 subtype. Adv Prostaglandin Thromboxane Leukot Res (1995) 0.87
Thioredoxin inhibits tumor necrosis factor- or interleukin-1-induced NF-kappaB activation at a level upstream of NF-kappaB-inducing kinase. Antioxid Redox Signal (2000) 0.87
Obovatol and obovatal, novel biphenyl ether lignans from the leaves of Magnolia obovata Thunb. Chem Pharm Bull (Tokyo) (1982) 0.87
[Studies on flavonoids from Fenugreek (Trigonella foenumgraecum L.)]. Zhongguo Zhong Yao Za Zhi (1998) 0.87
Anti-metastatic and immunomodulating properties of the water extract from Celosia argentea seeds. Biol Pharm Bull (1998) 0.87
Selective coupling of prostaglandin E receptor EP3D to Gi and Gs through interaction of alpha-carboxylic acid of agonist and arginine residue of seventh transmembrane domain. J Biol Chem (1995) 0.86
Utilization of the lateral circumflex femoral artery as a midway outflow for aorto-popliteal grafting: report of a case. Surg Today (1998) 0.86
A new antiplatelet diarylheptanoid from Alpinia blepharocalyx. J Nat Prod (1998) 0.86
Structure and function of prostanoid receptors. J Lipid Mediat (1993) 0.86
Characteristics and mechanism of neuromuscular block in myasthenia gravis. Ann N Y Acad Sci (1976) 0.86
Reversible inhibition of hypoxia-inducible factor 1 activation by exposure of hypoxic cells to the volatile anesthetic halothane. FEBS Lett (2001) 0.86
Hepatoprotective effect of Hovenia dulcis THUNB. on experimental liver injuries induced by carbon tetrachloride or D-galactosamine/lipopolysaccharide. Biol Pharm Bull (1997) 0.85
Surgical results of abdominal aortic aneurysm repair in patients with chronic renal dysfunction. Jpn Circ J (1997) 0.85
Responses of intercostal muscle biopsies from normal subjects and patients with myasthenia gravis. Muscle Nerve (1990) 0.85
Tribulusamide A and B, new hepatoprotective lignanamides from the fruits of Tribulus terrestris: indications of cytoprotective activity in murine hepatocyte culture. Planta Med (1998) 0.85